Exact Mass: 457.21683040000005
Exact Mass Matches: 457.21683040000005
Found 172 metabolites which its exact mass value is equals to given mass value 457.21683040000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
O-Demethylpuromycin
C21H27N7O5 (457.20735720000005)
A derivative of puromycin lacking the O-methyl group on the tyrosyl residue.
Acolbifene
C29H31NO4 (457.22529660000004)
methyl (6aS,11R,12bS)-5,6,6a,7,9,10,11,12,12a,12b-decahydro-13-hydroxy-3-{2-[(methoxycarbonyl)oxy]ethyl}-10,12b-dimethyl-4-oxo-4H-11,1-(metheno)azuleno[4,5-a]indolizine-2-carboxylate|paxiphylline C
Ala Cys His Lys
C18H31N7O5S (457.21072760000004)
Ala Cys Lys His
C18H31N7O5S (457.21072760000004)
Ala His Cys Lys
C18H31N7O5S (457.21072760000004)
Ala His Lys Cys
C18H31N7O5S (457.21072760000004)
Ala Lys Cys His
C18H31N7O5S (457.21072760000004)
Ala Lys His Cys
C18H31N7O5S (457.21072760000004)
Cys Ala His Lys
C18H31N7O5S (457.21072760000004)
Cys Ala Lys His
C18H31N7O5S (457.21072760000004)
Cys His Ala Lys
C18H31N7O5S (457.21072760000004)
Cys His Lys Ala
C18H31N7O5S (457.21072760000004)
Cys Lys Ala His
C18H31N7O5S (457.21072760000004)
Cys Lys His Ala
C18H31N7O5S (457.21072760000004)
Asp Ile Asn Pro
Asp Ile Pro Asn
Asp Leu Asn Pro
Asp Leu Pro Asn
Asp Asn Ile Pro
Asp Asn Leu Pro
Asp Asn Pro Ile
Asp Asn Pro Leu
Asp Pro Ile Asn
Asp Pro Leu Asn
Asp Pro Asn Ile
Asp Pro Asn Leu
Asp Pro Gln Val
Asp Pro Val Gln
Asp Gln Pro Val
Asp Gln Val Pro
Asp Val Pro Gln
Asp Val Gln Pro
Glu Asn Pro Val
Glu Asn Val Pro
Glu Pro Asn Val
Glu Pro Val Asn
Glu Val Asn Pro
Glu Val Pro Asn
His Ala Cys Lys
C18H31N7O5S (457.21072760000004)
His Ala Lys Cys
C18H31N7O5S (457.21072760000004)
His Cys Ala Lys
C18H31N7O5S (457.21072760000004)
His Cys Lys Ala
C18H31N7O5S (457.21072760000004)
His Lys Ala Cys
C18H31N7O5S (457.21072760000004)
His Lys Cys Ala
C18H31N7O5S (457.21072760000004)
Ile Asp Asn Pro
Ile Asp Pro Asn
Ile Asn Asp Pro
Ile Asn Pro Asp
Ile Pro Asp Asn
Ile Pro Asn Asp
Lys Ala Cys His
C18H31N7O5S (457.21072760000004)
Lys Ala His Cys
C18H31N7O5S (457.21072760000004)
Lys Cys Ala His
C18H31N7O5S (457.21072760000004)
Lys Cys His Ala
C18H31N7O5S (457.21072760000004)
Lys His Ala Cys
C18H31N7O5S (457.21072760000004)
Lys His Cys Ala
C18H31N7O5S (457.21072760000004)
Leu Asp Asn Pro
Leu Asp Pro Asn
Leu Asn Asp Pro
Leu Asn Pro Asp
Leu Pro Asp Asn
Leu Pro Asn Asp
Asn Asp Ile Pro
Asn Asp Leu Pro
Asn Asp Pro Ile
Asn Asp Pro Leu
Asn Glu Pro Val
Asn Glu Val Pro
Asn Ile Asp Pro
Asn Ile Pro Asp
Asn Leu Asp Pro
Asn Leu Pro Asp
Asn Pro Asp Ile
Asn Pro Asp Leu
Asn Pro Glu Val
Asn Pro Ile Asp
Asn Pro Leu Asp
Asn Pro Val Glu
Asn Val Glu Pro
Asn Val Pro Glu
Pro Asp Ile Asn
Pro Asp Leu Asn
Pro Asp Asn Ile
Pro Asp Asn Leu
Pro Asp Gln Val
Pro Asp Val Gln
Pro Glu Asn Val
Pro Glu Val Asn
Pro Ile Asp Asn
Pro Ile Asn Asp
Pro Leu Asp Asn
Pro Leu Asn Asp
Pro Asn Asp Ile
Pro Asn Asp Leu
Pro Asn Glu Val
Pro Asn Ile Asp
Pro Asn Leu Asp
Pro Asn Val Glu
Pro Gln Asp Val
Pro Gln Val Asp
Pro Val Asp Gln
Pro Val Glu Asn
Pro Val Asn Glu
Pro Val Gln Asp
Gln Asp Pro Val
Gln Asp Val Pro
Gln Pro Asp Val
Gln Pro Val Asp
Gln Val Asp Pro
Gln Val Pro Asp
Val Asp Pro Gln
Val Asp Gln Pro
Val Glu Asn Pro
Val Glu Pro Asn
Val Asn Glu Pro
Val Asn Pro Glu
Val Pro Asp Gln
Val Pro Glu Asn
Val Pro Asn Glu
Val Pro Gln Asp
Val Gln Asp Pro
Val Gln Pro Asp
2-amino-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-1H-purin-6(9H)-one
(2S)-3-amino-4-(4-tert-butylphenyl)-2-(9H-fluoren-9-ylmethoxycarbonyl)butanoic acid
C29H31NO4 (457.22529660000004)
(2R)-3-amino-4-(4-tert-butylphenyl)-2-(9H-fluoren-9-ylmethoxycarbonyl)butanoic acid
C29H31NO4 (457.22529660000004)
GDC-0068
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Ipatasertib (GDC-0068) is an orally active, highly selective and ATP-competitive pan-Akt inhibitor with IC50 values of 5, 18, 8 nM for Akt1/2/3, respectively. Ipatasertib synchronously activates FoxO3a and NF-κB through inhibition of Akt leading to p53-independent activation of PUMA. Ipatasertib also induces apoptosis in cancer cells and inhibits tumor growth in xenograft mouse models[1][2].
2-imino-8-methyl-5-oxo-1-(2-oxolanylmethyl)-N-(2-phenylethyl)-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxamide
6((S)-3-Benzylpiperazin-1-YL)-3-(naphthalen-2-YL)-4-(pyridin-4-YL)pyrazine
1-(2-{[(6-Amino-2-Methylpyridin-3-Yl)methyl]amino}ethyl)-6-Chloro-3-[(2,2-Difluoro-2-Pyridin-2-Ylethyl)amino]-1,4-Dihydropyrazin-2-Ol
C20H30ClF2N7O (457.21683040000005)
2-amino-N-[(2R,3R,4S,5S)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-hydroxyphenyl)propanamide
C21H27N7O5 (457.20735720000005)
3-Benzyl-4-(3-(cyclohexylmethyl)-4-methoxybenzamido)benzoic acid
C29H31NO4 (457.22529660000004)
4-[4-[[1-[(4-Methoxyphenyl)methyl]-5-tetrazolyl]-(3-pyridinyl)methyl]-1-piperazinyl]phenol
1-[3-[1-Cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl ester
3-(4-ethylphenyl)-4-hydroxy-4-(4-pyridin-2-ylpiperazine-1-carbonyl)-1H-quinazolin-2-one
(E)-4-(dimethylamino)-N-[3-[(5,11-dimethyl-6-oxopyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]phenyl]but-2-enamide
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(5-pyrimidinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(5as,6s,7ar,8r,9s,11as,11bs,12r)-6,9,12-trihydroxy-8-(hydroxymethyl)-5a,8,11a-trimethyl-3-(pyridin-3-yl)-6,7,7a,9,10,11,11b,12-octahydro-2,5-dioxatetraphen-1-one
(3s,4r,5s,7r,8r,9r,10s)-10-(3,5-dihydroxyphenyl)-4-hydroxy-8-[(2-hydroxyphenyl)amino]-3,5,7,9-tetramethyloxecane-2,6-dione
(2s)-2-amino-n-[(2s,3s,4r,5r)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-hydroxyphenyl)propanimidic acid
C21H27N7O5 (457.20735720000005)
methyl (1r,2s,6s,15s,16r)-18-hydroxy-11-{2-[(methoxycarbonyl)oxy]ethyl}-2,15-dimethyl-9-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-10(14),11,13(18)-triene-12-carboxylate
methyl 18-hydroxy-11-{2-[(methoxycarbonyl)oxy]ethyl}-2,15-dimethyl-9-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-10(14),11,13(18)-triene-12-carboxylate
(3r,4r,5s,7r,8r,9r,10s)-10-(3,5-dihydroxyphenyl)-4-hydroxy-8-[(2-hydroxyphenyl)amino]-3,5,7,9-tetramethyloxecane-2,6-dione
2-amino-n-[(2s,3s,4r,5r)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-hydroxyphenyl)propanimidic acid
C21H27N7O5 (457.20735720000005)